ExploreInterventionFollow-up colonoscopy
Intervention

Follow-up colonoscopy

Also known as: Follow-up colonoscopy at shorter-than-guideline-recommended intervals
3 findings 1 paper 3 related entities View in graph →

Related entities

conditions
outcomes
studys

Findings (27)

None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter
None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter
None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter
None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter
None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter
None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter
None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter
None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter
None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter
None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter
None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter
None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter
None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter
None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter
None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter
None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter
None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter
None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter
None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter
None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter
None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter
None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter
None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter
None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter
None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter
None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter
None
adverse

One-third (34%) of patients who underwent colonoscopy received follow-up interval recommendations shorter than multispecialty guidelines, while only 2% had longer intervals, with hyperplastic polyps (

Effect: adverse; 34% of patients had shorter-than-recommended follow-up intervals

Size: 34% of patients had shorter-than-recommended follow-up inter

Papers (1)